T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
VSE Corp
VSEC
$6.48B
| $500K | ﹤0.01% |
6,246
+465
| +8% | +$31.8K |
|
|
PFC
2202
DELISTED
Premier Financial Corp. Common Stock
PFC
| $500K | ﹤0.01% |
24,630
+1,473
| +6% | +$30.7K |
|
2203
Adaptive Biotechnologies
ADPT
$3.89B
| $499K | ﹤0.01% |
155,229
-137,655
| -47% | -$533K |
|
2204
Healthcare Services Group
HCSG
$1.45B
| $498K | ﹤0.01% |
39,830
+3,252
| +9% | +$36.1K |
|
2205
iShares Biotechnology ETF
IBB
$9.77B
| $496K | ﹤0.01% |
3,614
| – | – |
|
|
HOUS
2206
DELISTED
Anywhere Real Estate
HOUS
| $495K | ﹤0.01% |
79,989
+4,527
| +6% | +$29.8K |
|
2207
Movado Group
MOV
$796M
| $495K | ﹤0.01% |
17,719
+779
| +5% | +$21.8K |
|
2208
Amneal Pharmaceuticals
AMRX
$6.02B
| $493K | ﹤0.01% |
81,264
+5,146
| +7% | +$29K |
|
|
NLOP
2209
Net Lease Office Properties
NLOP
$173M
| $493K | ﹤0.01% |
20,680
+854
| +4% | +$20.1K |
|
|
VBTX
2210
DELISTED
Veritex Holdings
VBTX
| $493K | ﹤0.01% |
24,014
+2,162
| +10% | +$44.7K |
|
2211
Consensus Cloud Solutions
CCSI
$717M
| $492K | ﹤0.01% |
30,994
+4,100
| +15% | +$73.5K |
|
2212
The RMR Group
RMR
$346M
| $491K | ﹤0.01% |
20,446
+830
| +4% | +$20.8K |
|
2213
Greenlight Captial
GLRE
$512M
| $486K | ﹤0.01% |
38,958
+1,323
| +4% | +$15.5K |
|
2214
Gogo Inc
GOGO
$377M
| $485K | ﹤0.01% |
55,236
+11,505
| +26% | +$104K |
|
2215
Compass
COMP
$10.2B
| $484K | ﹤0.01% |
134,286
+9,804
| +8% | +$34.6K |
|
2216
Dutch Bros
BROS
$8.93B
| $482K | ﹤0.01% |
14,600
| – | – |
|
2217
Liberty Live Group Series A
LLYVA
$9.59B
| $482K | ﹤0.01% |
11,366
+647
| +6% | +$24.1K |
|
|
MODV
2218
DELISTED
ModivCare
MODV
| $481K | ﹤0.01% |
20,483
+608
| +3% | +$22.3K |
|
2219
IDT Corp
IDT
$1.67B
| $479K | ﹤0.01% |
12,647
+635
| +5% | +$22.7K |
|
2220
Orthofix Medical
OFIX
$415M
| $479K | ﹤0.01% |
32,957
+1,236
| +4% | +$17.1K |
|
2221
Harmony Biosciences
HRMY
$2.24B
| $478K | ﹤0.01% |
14,219
+1,201
| +9% | +$38.5K |
|
2222
National Presto Industries
NPK
$987M
| $475K | ﹤0.01% |
5,664
+774
| +16% | +$61.2K |
|
2223
Arcutis Biotherapeutics
ARQT
$3.25B
| $474K | ﹤0.01% |
47,753
+1,681
| +4% | +$12.5K |
|
2224
Hain Celestial
HAIN
$53.9M
| $473K | ﹤0.01% |
60,167
+6,493
| +12% | +$64K |
|
2225
Energy Recovery
ERII
$399M
| $470K | ﹤0.01% |
29,756
+2,018
| +7% | +$32.1K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.